What is Edwards Lifesciences's acquisitions?

Edwards Lifesciences (EW) reported acquisitions of $6.3M in Q1 2026.

What does acquisitions mean?

Cash paid for business acquisitions net of cash acquired in the target company — the primary M&A cash flow line.

Edwards Lifesciences EW Acquisitions

Acquisitions at other companies

AbbottABT

$20M—

Merit Medical SystemsMMSI

$1M0.0%

Boston ScientificBSX

$523M+119%

LeMaitre VascularLMAT

$45K+2.3%

MedtronicMDT

$406M—

HaemoneticsHAE

$60.18M—

Other financials

Income statement

See full

Revenue$1.7B+13.6%

Gross profit$1.3B+13.5%

Operating income$513.2M+24.8%

Net income$241.9M-27.4%

EPS (diluted)$0.42-25.0%

Balance sheet

See full

Cash & equivalents$2.4B-22.3%

Total debt$702.9M+0.5%

Total equity$10.3B+2.0%

Total assets$13.3B+2.3%

Cash flow

See full

Operating cash flow$43.8M-84.4%

CapEx$64.9M+15.9%

Free cash flow-$21.1M-109%

Valuation

See full

Market cap$48.18B+3.7%

Enterprise value$46.44B+11.0%

P/E48×+36.7×

P/S7.4×-0.8×

Profitability

See full

Gross margin77.8%-1.0pp

Operating margin22.3%-3.6pp

Net margin15.4%-57.5pp

FCF margin17.3%—

Returns & leverage

See full

Return on equity10.7%-37.8pp

Debt / equity0.1×0.0×

Current ratio4.4×0.0×

Where this comes from

Reported directly by Edwards Lifesciences in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquireInterestInSubsidiariesAndAffiliates.

The official record: Edwards Lifesciences’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Edwards Lifesciences's acquisitions.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Edwards Lifesciences's acquisitions?: Edwards Lifesciences (EW) reported acquisitions of $6.3M in Q1 2026.
What does acquisitions mean?: Cash paid for business acquisitions net of cash acquired in the target company — the primary M&A cash flow line.